Next, we ruled out the possibility that p53-independent p21CIP1 activation in bronchi/bronchioles and in non-tumor alveolar parenchyma might be ascribable to a prolonged effect of BRAFV600E chronic activation, which may be spontaneously occurred at some earlier time-points before tamoxifen injections. The gene discussed is CDKN1A; the disease is neoplasm.